Bank of America’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Buy |
897,070
+198,762
| +28% | +$737K | ﹤0.01% | 3636 |
|
|
2025
Q1 | $2.26M | Buy |
698,308
+313,428
| +81% | +$1.01M | ﹤0.01% | 3840 |
|
|
2024
Q4 | $2.14M | Buy |
384,880
+116,024
| +43% | +$646K | ﹤0.01% | 3697 |
|
|
2024
Q3 | $2.91M | Buy |
268,856
+41,257
| +18% | +$446K | ﹤0.01% | 3593 |
|
|
2024
Q2 | $4.78M | Buy |
227,599
+108,042
| +90% | +$2.27M | ﹤0.01% | 3140 |
|
|
2024
Q1 | $3.81M | Sell |
119,557
-45,799
| -28% | -$1.46M | ﹤0.01% | 3260 |
|
|
2023
Q4 | $3.35M | Buy |
165,356
+27,826
| +20% | +$564K | ﹤0.01% | 3235 |
|
|
2023
Q3 | $1.75M | Buy |
137,530
+35,022
| +34% | +$446K | ﹤0.01% | 3651 |
|
|
2023
Q2 | $1.85M | Sell |
102,508
-90,375
| -47% | -$1.63M | ﹤0.01% | 3606 |
|
|
2023
Q1 | $3.32M | Buy |
192,883
+115,471
| +149% | +$1.98M | ﹤0.01% | 3342 |
|
|
2022
Q4 | $1.72M | Buy |
77,412
+57,509
| +289% | +$1.28M | ﹤0.01% | 3790 |
|
|
2022
Q3 | $160K | Sell |
19,903
-2,044
| -9% | -$16.4K | ﹤0.01% | 5309 |
|
|
2022
Q2 | $153K | Sell |
21,947
-86,033
| -80% | -$600K | ﹤0.01% | 5498 |
|
|
2022
Q1 | $1.63M | Buy |
107,980
+20,533
| +23% | +$311K | ﹤0.01% | 4160 |
|
|
2021
Q4 | $1.92M | Buy |
87,447
+74,824
| +593% | +$1.64M | ﹤0.01% | 3948 |
|
|
2021
Q3 | $341K | Buy |
12,623
+1,608
| +15% | +$43.4K | ﹤0.01% | 5112 |
|
|
2021
Q2 | $265K | Buy |
11,015
+4,138
| +60% | +$99.6K | ﹤0.01% | 5131 |
|
|
2021
Q1 | $297K | Buy |
6,877
+6,837
| +17,093% | +$295K | ﹤0.01% | 5112 |
|
|
2020
Q4 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 6151 |
|